This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 16 for:    MCI charite
Previous Study | Return to List | Next Study

Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS

This study is currently recruiting participants.
See Contacts and Locations
Verified December 2016 by Agnes Flöel, Charite University, Berlin, Germany
Sponsor:
Information provided by (Responsible Party):
Agnes Flöel, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT02110043
First received: February 13, 2014
Last updated: December 20, 2016
Last verified: December 2016
  Purpose
The aim of this study is to investigate whether a combination of intensive training of visual-spatial abilities (LOCATO task) with anodal transcranial direct current stimulation (tDCS) leads to an improvement in learning and memory in patients with mild cognitive impairment (MCI) and to examine the underlying neuronal mechanism.

Condition Intervention
Mild Cognitive Impairment (MCI) Device: tDCS Behavioral: training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by Transcranial Direct Current Stimulation - Proof of Principle and Mechanisms

Further study details as provided by Agnes Flöel, Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Performance in LOCATO task (Visual-spatial learning and memory) after a combination of intensive visual-spatial training and tDCS [ Time Frame: immediately after end of a 3-day period of training in tDCS condition vs sham condition ]
    Investigation whether the combination of intensive visual-spatial training (LOCATO task) and tDCS leads to improvement of visual-spatial learning and memory measured by performance in LOCATO task after end of a 3 day period of training compared to sham stimulation.


Secondary Outcome Measures:
  • long term effects [ Time Frame: after 1 month vs baseline ]
    long term effects measured by performance in LOCATO task in tDCS condition after end of cognitve training and after 1 month compared to control conditions

  • functional changes: Connectivity [ Time Frame: end of 3-day cognitive training vs baseline ]
    Connectivity (measured by resting-state fMRT and correlation analysis) at baseline compared to end of 3 day period of training

  • cortical excitability [ Time Frame: at baseline ]
    cortical excitability measured by transcranial magnetic stimulation (TMS)

  • Quality of Life [ Time Frame: after 1 month vs baseline ]
    quality of life as measured by standardized questionaire at baseline compared to quality of life measured 1 month after intervention (training and stimulation vs. training and sham-stimualtion)

  • memory [ Time Frame: immediately after end of 3-day of cognitive training, after 1 month vs. baseline ]
    memory performance tested at baseline compared to memory performance after the end of a 3-day cognitive training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation

  • affective state [ Time Frame: immediately after the end of 3-day cognitive training, after 1 month vs. baseline ]
    affective state measured at baseline compared to affective state measured after the end of a 3-day cognitve training period and after 1 month (posttraining) in training and stimulation vs. training and sham stimulation

  • genotyping of learning related polymorphisms [ Time Frame: once ]
    To assess predictors of positive reaction to brain stimulation, genotyping of several learning related polymorphisms will be performed (i.e., APOE, BDNF Val66Met, COMT Val158Met).


Estimated Enrollment: 22
Study Start Date: March 2014
Estimated Study Completion Date: October 2017
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: training + tDCS
Combination of intensive training of visual-spatial abilities (LOCATO task) with anodal transcranial direct current stimulation (tDCS)
Device: tDCS
transcranial direct current stimulation (tDCS)
Behavioral: training
intensive training of visual-spatial abilities (in LOCATO task)
Sham Comparator: training + sham stimulation
Combination of intensive training of visual-spatial abilities (LOCATO task) with sham stimulation
Device: tDCS
transcranial direct current stimulation (tDCS)
Behavioral: training
intensive training of visual-spatial abilities (in LOCATO task)

  Eligibility

Ages Eligible for Study:   50 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria (MCI patients):

  • right handedness
  • amnestic and amnestic plus MCI with:

    1. subjective memory impairment;
    2. objective memory difficulties, at least 1 SD below gender, age and education adjusted standard values;
    3. relatively normal performance in other cognitive domains;
    4. no constraints in activities of daily livings
    5. age: 50-90 years

Exclusion Criteria:

  • severe internal or psychiatric disease
  • epilepsy
  • other severe neurological diseases, e.g. previous major stroke or brain tumor
  • DMS-IV manifest dementia
  • contraindication for MRT (claustrophobia, metallic implants, tattoos)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02110043

Contacts
Contact: Agnes Flöel, Prof. Dr. 0049 30 450 560284 agnes.floeel@charite.de
Contact: Nadine Külzow, Dr. 0049 30 450 560 140 nadine.kuelzow@charite.de

Locations
Germany
Charite Universitätsmedizin Berlin Recruiting
Berlin, Germany, 10117
Contact: Agnes Flöel, Prof. Dr.    0049 30 450560284    agnes.floeel@charite.de   
Principal Investigator: Agnes Flöel, Prof. Dr.         
Sponsors and Collaborators
Charite University, Berlin, Germany
Investigators
Principal Investigator: Agnes Flöel, Prof. Dr. Charite University, Berlin, Germany
  More Information

Responsible Party: Agnes Flöel, Prof. Dr., Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT02110043     History of Changes
Other Study ID Numbers: LOCATO-MCI-tDCS
Study First Received: February 13, 2014
Last Updated: December 20, 2016

Keywords provided by Agnes Flöel, Charite University, Berlin, Germany:
mild cognitive impairment (MCI)
tDCS
LOCATO task
visual-spatial learning

Additional relevant MeSH terms:
Cognition Disorders
Mild Cognitive Impairment
Neurocognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 23, 2017